Last reviewed · How we verify

NCT03629808

Laparoscopic Sleeve Gastrectomy: a Cohort Study

Completed Last updated 22 April 2020
What this trial tests

trial testing 4-6cm from starting point of gastrectomy to pylorus in Laparoscopic Sleeve Gastrectomy in 138 participants. Completed in 20 April 2020.

Timeline
10 July 2018
Primary endpoint
28 March 2020
20 April 2020

Quick facts

Lead sponsorBeijing Friendship Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment138
Start date10 July 2018
Primary completion28 March 2020
Estimated completion20 April 2020
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Beijing Friendship Hospital

Who can join

Adults 15 to 65, any sex, with Laparoscopic Sleeve Gastrectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective cohort study, which subjects were obese patients requiring LSG surgery. LSG with different gastric resection starting points (2-4cm/4-6 cm from pylorus) as intervention method. The main observation is the incidence and extent of upper gastrointestinal symptoms (such as nausea, vomiting, retching, reflux, difficulty swallowing, etc.).In addition, secondary observations include the excess weight loss (%EWL) and postoperative complications. Aim to investigate the effects of LSG surgery in different starting points of gastric resection on postoperative upper gastrointestinal symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Laparoscopic Sleeve Gastrectomy

Currently open trials in the same condition.

Other Beijing Friendship Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03629808.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing